EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
|
作者：
Verma, J. [1 ]
Verma, D. [1 ]
Maria, A. [1 ]
机构：
[1] VRB Analyt Pvt Ltd, Thana, MH, India
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN154
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Oguzhan, G.
    Caliskan, Z.
    Kockaya, G.
    Kurnaz, M.
    Calli, C.
    Erturk, S. M.
    VALUE IN HEALTH, 2020, 23 : S50 - S50
  • [2] Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Yuwei Liu
    Jiahui Pan
    Fangbo Gao
    Wentao Xu
    Hongyu Li
    Xingshun Qi
    Advances in Therapy, 2023, 40 : 521 - 549
  • [3] Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Liu, Yuwei
    Pan, Jiahui
    Gao, Fangbo
    Xu, Wentao
    Li, Hongyu
    Qi, Xingshun
    ADVANCES IN THERAPY, 2023, 40 (02) : 521 - 549
  • [4] The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
    Wang, Bi-Cheng
    Cao, Ru-Bo
    Fu, Chen
    Chen, Wang-Bing
    Li, Pin-Dong
    Lin, Guo-He
    Qian, Xiao-Jun
    Li, Yun-Tian
    Liu, Quentin
    ORAL ONCOLOGY, 2020, 104
  • [5] Comparative Safety of PD-1/PD-L1 Inhibitors for Cancer Patients: Systematic Review and Network Meta-Analysis
    Huang, Ya-Fang
    Xie, Wen-Jie
    Fan, Hai-Yu
    Du, Juan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [6] Efficacy of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Peng, Tzu-Rong
    Yang, Li-Jou
    Wu, Ta-Wei
    TZU CHI MEDICAL JOURNAL, 2024, 36 (03): : 340 - 348
  • [7] The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: a systematic review and meta-analysis
    Xiao, Bo-Ya
    Lin, Guo-He
    Zhao, Yan-Xia
    Wang, Bi-Cheng
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (06) : 3804 - 3818
  • [8] Safety of PD-L1 inhibitors versus PD-1 inhibitors in the treatment of lung cancer: a systematic review and network meta-analysis
    Ding, Jianqiao
    Liu, Zheyu
    Ning, Jing
    Sun, Nan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2025, 25 (03) : 259 - 267
  • [9] Efficacy and safety of PD-1/PD-L1 inhibitors alone or in combination in the treatment of metastatic or advanced renal cell carcinoma: a network meta-analysis
    Zhang, Dongli
    Shen, Chong
    Zhang, Weichuan
    Chen, Haibin
    Zhao, Jianjun
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [10] Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis
    de Moraes, Francisco Cezar Aquino
    Kreuz, Michele
    de Lara, Isabella Christina Amaral
    Lobo, Artur de Oliveira Macena
    Burbano, Rommel Mario Rodriguez
    BMC CANCER, 2024, 24 (01)
12345